BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/6/2020 9:07:37 AM | Browse: 1026 | Download: 2596
 |
Received |
|
2020-05-28 07:45 |
|
Peer-Review Started |
|
2020-05-28 07:45 |
|
First Decision by Editorial Office Director |
|
2020-07-29 02:55 |
|
Return for Revision |
|
2020-08-25 11:55 |
|
Revised |
|
2020-09-11 15:13 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-09-22 09:13 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-09-22 20:23 |
|
Articles in Press |
|
2020-09-22 20:23 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-11-03 00:33 |
|
Publish the Manuscript Online |
|
2020-11-06 09:07 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Asad Izziddin Dajani and Branko Popovic |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Branko Popovic, MD, N/A, N/A, Sanofi-Aventis Deutschland GmbH, CHC Global Medical Affairs, Industriepark Höchst, Frankfurt am Main 65926, Germany. branko.popovic@sanofi.com |
| Key Words |
Non-alcoholic fatty liver disease; Diabetes; Obesity; Metabolic syndrome; Essential phospholipids; Systematic review |
| Core Tip |
Essential phospholipids (EPL) are used for the supportive treatment of non-alcoholic fatty liver disease, but the data are mostly from small-scale studies. Thus, we used meta-analytical techniques to assess the efficacy of EPL in patients with non-alcoholic fatty liver disease and type 2 diabetes and/or obesity. Our results indicate EPL provides benefit in this patient population, reducing alanine aminotransferase, triglyceride and cholesterol levels, and improving disease severity (as measured by ultrasonography). Larger-scale trials are warranted to confirm these findings. |
| Publish Date |
2020-11-06 09:07 |
| Citation |
Dajani AI, Popovic B. Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis. World J Clin Cases 2020; 8(21): 5235-5249 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i21/5235.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i21.5235 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
